Thomas N. Seyfried

Last updated

Thomas N. Seyfried (born 1946 [1] ) is an American professor of biology, genetics, and biochemistry at Boston College. He received his PhD from the University of Illinois Urbana-Champaign in 1976. His postdoctoral fellowship studies were in the Department of Neurology at the Yale University School of Medicine where he served as an assistant professor in neurology. He did undergraduate work at the University of New England, formerly St. Francis College, and received a master's degree in genetics from Illinois State University, Normal.

Research and views

His research focuses on mechanisms of chronic diseases such as cancer, epilepsy, neurodegenerative lipid storage diseases, and caloric restriction diets. [2] Thomas N. Seyfried has been published in over 150 peer-reviewed publications. [3] He previously served as chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro. His 2012 book is Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer. Seyfried is a popular interview guest regarding the metabolic theory of cancer.

Seyfried has been accused of suggesting that cancer patients should reject radiation therapy and chemotherapy. In one interview he claimed these treatments have only marginally improved long-term survival and described them as "medieval," instead favoring a ketogenic diet combined with metabolism-targeting drugs. [4] [5] [6] [7] However, in his peer-reviewed scientific publications, Seyfried has argued that dose-adjusted chemotherapy and radiation should be integrated into ketogenic metabolic therapy. [8] [9]

Personal life

Seyfried also served in the United States Army during the Vietnam War, receiving the Bronze Star, the Air Medal, and the Army Commendation Medal. [10] His father, William E. Seyfried, Sr., served in the United States Merchant Marine during World War II and was president and founder of Capeway Paints in Brockton, Massachusetts. [11] His brother William E. Seyfried, Jr. is a University of Minnesota professor in the Department of Earth and Environmental Sciences who obtained a PhD from the University of Southern California. [12] Thomas Seyfried and his wife Karen live in Foxboro, Massachusetts. [13] [14]

Related Research Articles

<span class="mw-page-title-main">Isoleucine</span> Chemical compound

Isoleucine (symbol Ile or I) is an α-amino acid that is used in the biosynthesis of proteins. It contains an α-amino group (which is in the protonated −NH+3 form under biological conditions), an α-carboxylic acid group (which is in the deprotonated −COO form under biological conditions), and a hydrocarbon side chain with a branch (a central carbon atom bound to three other carbon atoms). It is classified as a non-polar, uncharged (at physiological pH), branched-chain, aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it. Essential amino acids are necessary in the human diet. In plants isoleucine can be synthesized from threonine and methionine. In plants and bacteria, isoleucine is synthesized from a pyruvate employing leucine biosynthesis enzymes. It is encoded by the codons AUU, AUC, and AUA.

<span class="mw-page-title-main">Ketosis</span> Using body fats as fuel instead of carbohydrates

Ketosis is a metabolic state characterized by elevated levels of ketone bodies in the blood or urine. Physiological ketosis is a normal response to low glucose availability. In physiological ketosis, ketones in the blood are elevated above baseline levels, but the body's acid–base homeostasis is maintained. This contrasts with ketoacidosis, an uncontrolled production of ketones that occurs in pathologic states and causes a metabolic acidosis, which is a medical emergency. Ketoacidosis is most commonly the result of complete insulin deficiency in type 1 diabetes or late-stage type 2 diabetes. Ketone levels can be measured in blood, urine or breath and are generally between 0.5 and 3.0 millimolar (mM) in physiological ketosis, while ketoacidosis may cause blood concentrations greater than 10 mM.

<span class="mw-page-title-main">Otto Heinrich Warburg</span> German physiologist and Nobel laureate (1883–1970)

Otto Heinrich Warburg was a German physiologist, medical doctor, and Nobel laureate. He served as an officer in the elite Uhlan during the First World War, and was awarded the Iron Cross for bravery. He was the sole recipient of the Nobel Prize in Physiology or Medicine in 1931. In total, he was nominated for the award 47 times over the course of his career.

<span class="mw-page-title-main">Low-carbohydrate diet</span> Diets restricting carbohydrate consumption

Low-carbohydrate diets restrict carbohydrate consumption relative to the average diet. Foods high in carbohydrates are limited, and replaced with foods containing a higher percentage of fat and protein, as well as low carbohydrate foods.

<span class="mw-page-title-main">Retinoid</span> Group of tetraterpenes

The retinoids are a class of chemical compounds that are natural derivatives of vitamin A or are chemically related to it. Synthetic retinoids are used in medicine where they regulate skin health, immunity and bone disorders.

Adjuvant therapy, also known as adjunct therapy, adjuvant care, or augmentation therapy, is a therapy that is given in addition to the primary or initial therapy to maximize its effectiveness. The surgeries and complex treatment regimens used in cancer therapy have led the term to be used mainly to describe adjuvant cancer treatments. An example of such adjuvant therapy is the additional treatment usually given after surgery where all detectable disease has been removed, but where there remains a statistical risk of relapse due to the presence of undetected disease. If known disease is left behind following surgery, then further treatment is not technically adjuvant.

Pyruvate dehydrogenase deficiency is a rare neurodegenerative disorder associated with abnormal mitochondrial metabolism. PDCD is a genetic disease resulting from mutations in one of the components of the pyruvate dehydrogenase complex (PDC). The PDC is a multi-enzyme complex that plays a vital role as a key regulatory step in the central pathways of energy metabolism in the mitochondria. The disorder shows heterogeneous characteristics in both clinical presentation and biochemical abnormality.

<span class="mw-page-title-main">Medium-chain triglyceride</span> Medium-chain fatty acids

A medium-chain triglyceride (MCT) is a triglyceride with two or three fatty acids having an aliphatic tail of 6–12 carbon atoms, i.e. a medium-chain fatty acid (MCFA). Rich food sources for commercial extraction of MCTs include palm kernel oil and coconut oil.

<span class="mw-page-title-main">Ketogenic amino acid</span> Type of amino acid

A ketogenic amino acid is an amino acid that can be degraded directly into acetyl-CoA, which is the precursor of ketone bodies and myelin, particularly during early childhood, when the developing brain requires high rates of myelin synthesis. This is in contrast to the glucogenic amino acids, which are converted into glucose. Ketogenic amino acids are unable to be converted to glucose as both carbon atoms in the ketone body are ultimately degraded to carbon dioxide in the citric acid cycle.

<span class="mw-page-title-main">Fatty acid-binding protein</span>

The fatty-acid-binding proteins (FABPs) are a family of transport proteins for fatty acids and other lipophilic substances such as eicosanoids and retinoids. These proteins are thought to facilitate the transfer of fatty acids between extra- and intracellular membranes. Some family members are also believed to transport lipophilic molecules from outer cell membrane to certain intracellular receptors such as PPAR. The FABPs are intracellular carriers that “solubilize” the endocannabinoid anandamide (AEA), transporting AEA to the breakdown by FAAH, and compounds that bind to FABPs block AEA breakdown, raising its level. The cannabinoids are also discovered to bind human FABPs that function as intracellular carriers, as THC and CBD inhibit the cellular uptake and catabolism of AEA by targeting FABPs. Competition for FABPs may in part or wholly explain the increased circulating levels of endocannabinoids reported after consumption of cannabinoids. Levels of fatty-acid-binding protein have been shown to decline with ageing in the mouse brain, possibly contributing to age-associated decline in synaptic activity.

<span class="mw-page-title-main">Metabolic myopathy</span> Muscular diseases caused by defects in metabolic processes

Metabolic myopathies are myopathies that result from defects in biochemical metabolism that primarily affect muscle. They are generally genetic defects that interfere with the ability to create energy, causing a low ATP reservoir within the muscle cell.

<span class="mw-page-title-main">ALDH1A1</span> Protein-coding gene in the species Homo sapiens

Aldehyde dehydrogenase 1 family, member A1, also known as ALDH1A1 or retinaldehyde dehydrogenase 1 (RALDH1), is an enzyme that is encoded by the ALDH1A1 gene.

<span class="mw-page-title-main">Hodgkin lymphoma</span> Type of blood and immune-system cancer

Hodgkin lymphoma (HL) is a type of lymphoma in which cancer originates from a specific type of white blood cell called lymphocytes, where multinucleated Reed–Sternberg cells are present in the patient's lymph nodes. The condition was named after the English physician Thomas Hodgkin, who first described it in 1832. Symptoms may include fever, night sweats, and weight loss. Often, nonpainful enlarged lymph nodes occur in the neck, under the arm, or in the groin. Persons affected may feel tired or be itchy.

<span class="mw-page-title-main">The Hallmarks of Cancer</span> 2000 paper by Hanahan and Weinberg

The hallmarks of cancer were originally six biological capabilities acquired during the multistep development of human tumors and have since been increased to eight capabilities and two enabling capabilities. The idea was coined by Douglas Hanahan and Robert Weinberg in their paper "The Hallmarks of Cancer" published January 2000 in Cell.

<span class="mw-page-title-main">Lipidology</span>

Lipidology is the scientific study of lipids. Lipids are a group of biological macromolecules that have a multitude of functions in the body. Clinical studies on lipid metabolism in the body have led to developments in therapeutic lipidology for disorders such as cardiovascular disease.

<span class="mw-page-title-main">Christos Socrates Mantzoros</span> Greek American physician and scientist

Christos Socrates Mantzoros is a Greek-born American physician-scientist, practicing internist-endocrinologist, teacher and researcher. He is a professor of medicine at Harvard Medical School and an adjunct professor at Boston University School of Medicine. He currently serves as the chief of endocrinology, diabetes and metabolism at the VA Boston Healthcare System, where he created de novo a leading academic division true to its tripartite mission and as the founding director of human nutrition at Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School. Finally, he holds the editor-in-chief position of the journal Metabolism: Clinical and Experimental.

Jason W. Locasale is an American scientist and university professor. His focus is on metabolism.

Christine Denny is an American neuroscientist and associate professor of Clinical Neurobiology in Psychiatry in the Department of Psychiatry at Columbia University Irving Medical Center in New York City. Denny investigates the molecular mechanisms underlying learning and memory. She developed a novel technique to label neurons that encode specific memories. She used this technique to probe what happens to hippocampal memory traces in different disease states.

The metabolic theory of cancer is a label for claims that the primary cause of cancer is changes in cellular metabolism, meaning that changes in diet are likely to be effective treatment for cancer. These claims are promoted by commercial interests selling foods and food additives, supported by a small number of scientists. These claims deploy the scientific consensus that certain kinds of cancer cells have abnormal metabolic needs and behaviors, while falsely presenting this fact as if it were rejected by orthodox science.

Lingyan Shi is an associate professor in the Shu Chien-Gene Lay Department of Bioengineering in Jacobs School of Engineering, University of California, San Diego.

References

  1. "Interview with Thomas N. Seyfried on Cancer as a metabolic disease: On the origin, management, and prevention of cancer" . Retrieved 2023-03-12.
  2. "Biology Department Faculty: Thomas N. Seyfried, professor" . Retrieved 2023-03-12.
  3. "An overview of publications and citations of Thomas N Seyfried" . Retrieved 2023-03-12.
  4. The Diary Of A CEO (2024-10-07). The Cancer Expert: "This Common Food Is Making Cancer Worse!" . Retrieved 2024-12-17 via YouTube.
  5. "Steven Bartlett sharing harmful health misinformation on Diary of CEO podcast". www.bbc.com. Retrieved 2024-12-17.
  6. Wilson, Clare (2024-12-13). "Four wildest health claims in Steven Bartlett's Diary of a CEO podcast debunked". The i Paper. Retrieved 2024-12-17.
  7. Ladanie, Aviv; Schmitt, Andreas M.; Speich, Benjamin; Naudet, Florian; Agarwal, Arnav; Pereira, Tiago V.; Sclafani, Francesco; Herbrand, Amanda K.; Briel, Matthias; Martin-Liberal, Juan; Schmid, Thomas; Ewald, Hannah; Ioannidis, John P. A.; Bucher, Heiner C.; Kasenda, Benjamin (2020-11-10). "Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016". JAMA Network Open. 3 (11): e2024406. doi:10.1001/jamanetworkopen.2020.24406. ISSN   2574-3805. PMC   7656288 . PMID   33170262.
  8. Seyfried, Thomas N.; Yu, George; Maroon, Joseph C.; D’Agostino, Dominic P. (2017-02-23). "Press-pulse: a novel therapeutic strategy for the metabolic management of cancer". Nutrition & Metabolism. 14 (1): 19. doi: 10.1186/s12986-017-0178-2 . ISSN   1743-7075. PMC   5324220 . PMID   28250801.
  9. Duraj, Tomás; Kalamian, Miriam; Zuccoli, Giulio; Maroon, Joseph C.; D’Agostino, Dominic P.; Scheck, Adrienne C.; Poff, Angela; Winter, Sebastian F.; Hu, Jethro; Klement, Rainer J.; Hickson, Alicia; Lee, Derek C.; Cooper, Isabella; Kofler, Barbara; Schwartz, Kenneth A. (2024-12-05). "Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma". BMC Medicine. 22 (1): 578. doi: 10.1186/s12916-024-03775-4 . ISSN   1741-7015. PMC   11622503 . PMID   39639257.
  10. Seyfried, Thomas (26 June 2012). Thomas N. Seyfried bio at Amazon.com. John Wiley & Sons. ISBN   978-0470584927.
  11. "Obituary: William E. Seyfried, Sr., 85" . Retrieved 2023-03-12.
  12. "University of Minnesota: William Seyfried" . Retrieved 2023-03-12.
  13. "Roth, Gregory" . Retrieved 2023-03-12.
  14. "How to Starve Cancer & Heal the Body, Dr. Thomas Seyfried". YouTube . 7 March 2023. Retrieved 2023-03-12.

Further reading

Christofferson, Travis (2017). Tripping over the Truth: How the Metabolic Theory of Cancer Is Overturning One of Medicine's Most Entrenched Paradigms. Chelsea Green Publishing.